Skip to main content
Clinical Trials/NCT03768284
NCT03768284
Completed
Not Applicable

Genetic Analysis of Pediatric Psoriasis

Northwestern University1 site in 1 country86 target enrollmentOctober 17, 2018
ConditionsPsoriasis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psoriasis
Sponsor
Northwestern University
Enrollment
86
Locations
1
Primary Endpoint
CARD14 mutations
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study will ascertain approximately 150 subjects, which will include pediatric psoriasis patients diagnosed before age 12, parents not affected by psoriasis, and if a family history is indicated, up to third-degree family members. Saliva (or buccal swabs in the case of infants) will be obtained for DNA isolation.

Registry
clinicaltrials.gov
Start Date
October 17, 2018
End Date
December 30, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amy Paller

Principal Investigator

Northwestern University

Eligibility Criteria

Inclusion Criteria

  • Patients (of any age) who developed psoriasis before 12 years of age and who have no family history of psoriasis in either parent.
  • Parents of patients who developed psoriasis before 12 years of age
  • Up to third-degree family members (first cousin, grandparent, great-grandparent) with or without psoriasis, if family history is indicated.

Exclusion Criteria

  • Patients, parents, and other family member unable to give a saliva or buccal swab sample.
  • Patients, parents, and other family member unable to give written informed consent.

Outcomes

Primary Outcomes

CARD14 mutations

Time Frame: one year

The number of pathogenic mutations identified in CARD14 in a pediatric psoriasis cohort

Secondary Outcomes

  • De novo mutations(one year)

Study Sites (1)

Loading locations...

Similar Trials